Efficacy and safety of a botanical shampoo containing Morus alba root extract in Republic of Korea: a single-center, open-label, pilot study in mild to moderate non-scarring alopecia of the scalp
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Commonly known as white mulberry, Morus alba is widely used in traditional medicine for its various health benefits. Recently, the Morus alba root extract (MARE) has been reported to increase β-catenin expression and growth factor secretion related to the telogen-to-anagen transition, drawing attention to the possibilities as a complementary medicine to promote hair growth. This study aims to evaluate the efficacy and safety of a shampoo formulation containing MARE in mild to moderate non-scarring alopecia patients.Methods: This study was designed as a single-arm, prospective trial. Twenty non-scarring alopecia patients were administered a botanical shampoo containing MARE for 8 weeks. At 0, 4, 8, and 12 weeks, changes in the hair density and hair shaft thickness were assessed using a folliscope. Overall improvements (0-4 scale) were assessed by blinded investigators using standardized photographic comparisons. The patients scored their subjective satisfaction on a scale of 0-10.Results: Compared to the baseline, significant improvements were observed in the hair density and hair shaft thickness in the vertex at week 12. After 12 weeks, the average hair diameter increased from 50.83 ± 8.97 µm to 55.56 ± 9.31 µm in the vertex and from 60.06 ± 9.84 µm to 64.56 ± 6.79 µm in the occiput. Blinded investigators reported an average score of 3.1 ± 0.4 for improvements in alopecia. Participants were moderately satisfied with the overall results (7.2 ± 1.4).Conclusion: Results of this study indicate that a shampoo formulation containing MARE is a safe and convenient method for treating hair loss.
Abstract
Background: Commonly known as white mulberry, Morus alba is widely used in traditional medicine for its various health benefits. Recently, the Morus alba root extract (MARE) has been reported to increase β-catenin expression and growth factor secretion related to the telogen-to-anagen transition, drawing attention to the possibilities as a complementary medicine to promote hair growth. This study aims to evaluate the efficacy and safety of a shampoo formulation containing MARE in mild to moderate non-scarring alopecia patients.Methods: This study was designed as a single-arm, prospective trial. Twenty non-scarring alopecia patients were administered a botanical shampoo containing MARE for 8 weeks. At 0, 4, 8, and 12 weeks, changes in the hair density and hair shaft thickness were assessed using a folliscope. Overall improvements (0-4 scale) were assessed by blinded investigators using standardized photographic comparisons. The patients scored their subjective satisfaction on a scale of 0-10.Results: Compared to the baseline, significant improvements were observed in the hair density and hair shaft thickness in the vertex at week 12. After 12 weeks, the average hair diameter increased from 50.83 ± 8.97 µm to 55.56 ± 9.31 µm in the vertex and from 60.06 ± 9.84 µm to 64.56 ± 6.79 µm in the occiput. Blinded investigators reported an average score of 3.1 ± 0.4 for improvements in alopecia. Participants were moderately satisfied with the overall results (7.2 ± 1.4).Conclusion: Results of this study indicate that a shampoo formulation containing MARE is a safe and convenient method for treating hair loss.
참고문헌 (11)
- Mella JM, "Efficacy and safety of finasteride therapy for androgenetic alopecia : a systematic review", Arch Dermatol, 146, pp.1141~1150 (2010)
- Peluso AM, "Diffuse hypertrichosis during treatment with 5% topical minoxidil", Br J Dermatol, 136, pp.118~120 (1997)
- Dhariwala MY, "An overview of herbal alternatives in androgenetic alopecia", J Cosmet Dermatol, 18, pp.966~975 (2019)
- Prager N, "A randomized, double-blind, placebo-controlled trial to determine the effectiveness of botanically derived inhibitors of 5-alpha-reductase in the treatment of androgenetic alopecia", J Altern Complement Med, 8, pp.143~152 (2002)
- Anastassakis K, "Androgenetic alopecia from A to Z. Vol. 2, Drugs, herbs, nutrition and supplements", pp.429~439 (2022), Springer
- Datta K, "Eclipta alba extract with potential for hair growth promoting activity", J Ethnopharmacol, 124, pp.450~456 (2009)
- Begum S, "Exogenous stimulation with Eclipta alba promotes hair matrix keratinocyte proliferation and downregulates TGF-β1 expression in nude mice", Int J Mol Med, 35, pp.496~502 (2015)
- Yadav NK, "Alcoholic extract of Eclipta alba shows in vitro antioxidant and anticancer activity without exhibiting toxicological effects", Oxid Med Cell Longev, 2017, pp.9094641~ (2017)
- Bouayed J, "Chlorogenic acid, a polyphenol from Prunus domestica(Mirabelle), with coupled anxiolytic and antioxidant effects", J Neurol Sci, 262, pp.77~84 (2007)
- Hyun J, "Morus alba root extract induces the anagen phase in the human hair follicle dermal papilla cells", Pharmaceutics, 13, pp.1155~ (2021)
- Im Jisoo, "Enhancing the Angiogenic and Proliferative Capacity of Dermal Fibroblasts with Mulberry (Morus alba. L) Root Extract", 조직공학과 재생의학, 19(1), pp.49~57 (2022), 한국조직공학과 재생의학회[DOI]